Focusing on TP53, PTEN, and related tumor suppressor pathways, AntibodySystem provides comprehensive coverage of key targets including TP53, PTEN, RB1, MDM2, BRCA1, BRCA2, LKB1, and APC, as well as phospho-specific antibodies for AKT and mTOR signaling nodes. From mechanistic studies to target discovery, from drug efficacy evaluation to biomarker development, AntibodySystem continues to provide reliable research tools for oncology research.

AntibodySystem offers a comprehensive portfolio of research reagents supporting studies of Dengue virus (DENV), Chikungunya virus (CHIKV), Zika virus (ZIKV)

Because in flow cytometry, the greatest risk is not generating imperfect-looking plots. It is creating data that appears biologically convincing while being fundamentally misleading.

In summary, we provide a robust proof-of-concept study and show that CD19-ReTARGTPR offers a promising alternative strategy for T cell redirection, enabling the selective and effective killing of CD19-expressing malignancies while minimizing cytokine-driven toxicities through physiological CTL activation pathways.

This guide is designed to help you systematically interpret flow cytometry data, even if you are new to the technique. Rather than focusing on theory, it provides a structured approach to evaluating plots, identifying cell populations, and assessing data quality.

The pET vector series, originally developed by Novagen (now part of Merck), represents one of the most widely adopted T7-based expression platforms in Escherichia coli. Its popularity stems not from a single superior plasmid design, but from a modular, tightly regulated, and high-output transcription system.

This series of products are mouse monoclonal antibodies specifically targeting the IgM heavy chain constant region (IGHM) of various economically important fish species, recognizing both secreted IgM (serum/mucus) and membrane-bound IgM (B cell surface). All antibodies are purified by Protein A/G affinity, with purity >95%, and have been validated in multiple platforms including ELISA, FCM, IF, and WB, suitable for vaccine efficacy evaluation, B‑cell subset analysis, tissue expression detection, and immune monitoring.

Recent reports of Hand, Foot, and Mouth Disease (HFMD) in Japan have drawn increasing public health attention. According to the Japan Institute for Health Security (JIHS), the cumulative number of HFMD cases nationwide has exceeded 11,600 in 2026. During the week of May 25--31 alone, six prefectures, including Fukuoka, Miyazaki, and Kagoshima, reported case numbers above the official alert threshold, prompting local health authorities to issue outbreak warnings earlier than in previous years.

In May 2026, AntibodySystem products continued to support cutting-edge research across multiple scientific disciplines. Studies citing our reagents were published in journals including Science China Life Sciences, Journal of Translational Medicine, Cell Reports, European Journal of Medicinal Chemistry, and Journal of Medical Virology.

On May 18, the government of the Democratic Republic of the Congo (DRC) reported that the newly emerged Ebola outbreak in Ituri Province continues to spread. Authorities have recorded 116 suspected deaths, while another 435 suspected cases remain under observation and treatment. Meanwhile, neighboring Uganda has also reported a fatal imported case. The World Health Organization (WHO) has declared the outbreaks in the DRC and Uganda a "Public Health Emergency of International Concern (PHEIC)." Rwanda, Tanzania, Zambia, and other neighboring countries have subsequently strengthened border screening and public health surveillance measures. At a time when the global public health system is still recovering from the aftermath of COVID-19, the resurgence of Ebola virus — one of the world's most lethal pathogens — has once again drawn international attention.

In April 2026, AntibodySystem products continued to support cutting-edge multidisciplinary research, contributing to studies published in journals including Nature Publishing Group journals, Angewandte chemie International Edition, EMBO Molecular Medicine, Bioorganic Chemistry, Cancers, and Sensors. These studies span key areas such as early cancer diagnostics, bone metabolism disorders, renal fibrosis, neuroimaging, viral vaccines, and tumor immunotherapy, further advancing innovation in frontier technologies and translational medicine.

The recent outbreak aboard the Caribbean Princess serves as another reminder that norovirus remains one of the most challenging viral pathogens in public health settings, particularly in crowded and enclosed environments. Its exceptionally low infectious dose, environmental persistence, and rapid transmission dynamics continue to complicate outbreak control efforts worldwide. At the same time, the absence of robust culture systems and approved vaccines has posed significant scientific and technical barriers to therapeutic and vaccine development. Nevertheless, continued advances in organoid-based infection models, VLP technologies, recombinant protein platforms, and structural virology are rapidly accelerating progress in the field. Future studies focused on VP1, RdRp, and virus-host interaction mechanisms are expected to remain central to the development of next-generation norovirus vaccines and diagnostics.

Tumor-associated macrophages (TAMs) have long been regarded as key drivers of immunosuppression within the tumor microenvironment (TME), making them an attractive therapeutic target. Early strategies largely focused on reducing TAM abundance, under the assumption that their elimination would relieve immune suppression and enhance anti-tumor immunity.

For researchers new to hPSC-based neural differentiation, the most common challenge is not technical execution, but understanding why specific factors are added at each stage. At its core, neural differentiation of human pluripotent stem cells is a process of artificially recreating defined signaling environments, allowing cells to receive the right developmental cues at the right time. Understanding the function of these cues is far more important than memorizing differentiation recipes.

Cervical cancer ranks as the fourth most common cancer among women globally and is caused by persistent infection with the Human Papillomavirus (HPV), a small DNA virus known to infect the skin, genital areas, and throat. Based on disease severity, HPV is categorized into low-risk and high-risk types. Persistent infection with high-risk HPV, particularly types 16 and 18, is responsible for 70% of cervical cancer cases due to their potential to cause malignant tumors.

Glycosylation is a common post-translational modification in eukaryotic cells that plays a crucial role in protein folding, stability, activity, and intercellular signaling.

AntibodySystem offers a voucher program